Hormone-Receptor Expression and Ovarian Cancer Survival: An Ovarian Tumor Tissue Analysis Consortium Study

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(13)70253-5
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV

Related search

Association of P16 Expression With Prognosis Varies Across Ovarian Carcinoma Histotypes: An Ovarian Tumor Tissue Analysis Consortium Study

Journal of Pathology: Clinical Research
Forensic MedicinePathology
2018English

Hormone Therapy and Ovarian Cancer: Incidence and Survival

Cancer Causes and Control
Cancer ResearchOncology
2008English

Hormone Replacement Therapy and Survival After Surgery for Ovarian Cancer

International Journal of Gynecology and Obstetrics
MedicineGynecologyObstetrics
1991English

Hormone Replacement Therapy and Survival After Surgery for Ovarian Cancer.

BMJ
1991English

Vitamin D Receptor Rs2228570 Polymorphism and Invasive Ovarian Carcinoma Risk: Pooled Analysis in Five Studies Within the Ovarian Cancer Association Consortium

International Journal of Cancer
Cancer ResearchOncology
2010English

Predictors of Pretreatment CA125 at Ovarian Cancer Diagnosis: A Pooled Analysis in the Ovarian Cancer Association Consortium

Cancer Causes and Control
Cancer ResearchOncology
2017English

COX-2 Expression in Ovarian Cancer: An Updated Meta-Analysis

Oncotarget
Oncology
2017English

Expression of Trypsinogen-1, Trypsinogen-2, and Tumor-Associated Trypsin Inhibitor in Ovarian Cancer: Prognostic Study on Tissue and Serum

Clinical Cancer Research
Cancer ResearchOncology
2004English

A Clinically Applicable Molecular Classification for High-Grade Serous Ovarian Cancer Based on Hormone Receptor Expression

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy